Our company news

Smooth Drug Development September 2021 News Release

Published on Wednesday October 06, 2021

We are working on the following new projects: Our company was awarded with medical writing of an article based on the study report from Chronic Hepatitis C in Russian Federation.

Read more →

Smooth Drug Development August 2021 News Release

Published on Monday September 06, 2021

We are working on the following new projects: We are preparing a contract for a phase 1 clinical trial with Dalteparin sodium. Our company signed a contract signature for the observational program with a top ten pharma.

Read more →

Smooth Drug Development July 2021 News Release

Published on Friday August 06, 2021

We are working on the following new projects: Smooth is signing a contract for a bioequivalence trial of the Ibuprofen with our long-term client in Russia. Our company started activities for regulatory support for a global CRO.

Read more →

Smooth Drug Development June 2021 News Release

Published on Friday July 02, 2021

We are working on the following new projects: • Smooth won a bidding for the international phase III clinical trial of the original drug for the patients with chronic myeloid leukemia. The study will take place in India, Belarus, and Russia.

Read more →

Smooth Drug Development May 2021 News Release

Published on Tuesday June 01, 2021

We are working on the following new projects: • We signed 2 contracts with a new sponsor for bioequivalence studies of the drugs with INN Rivaroxaban (dosages 10 and 20 mg)

Read more →

Clinical Trials Day

Published on Thursday May 20, 2021

Clinical Trials Day is celebrated around the world 0n 20 of May.

Read more →

Smooth Drug Development March 2021 News Release

Published on Thursday April 01, 2021

We are working on the following new projects: • Smooth was awarded by 4 projects in Russia for medical writing and data management and 1 in Lithuania for data management.

Read more →

Smooth Drug Development February 2021 News Release

Published on Tuesday March 09, 2021

We are working on the following new projects: • We signed a WO for CTD modules preparation with our global Sponsor. • We signed 2 contracts for specification documents

Read more →

Smooth Drug Development January 2021 News Release

Published on Tuesday February 02, 2021

We are happy to present our new signed projects: • Contract for CTA submission of the final report with a new Sponsor. • Agreement for a bioequivalence study (INN: Dutasteride + Tamsulosin).

Read more →

Smooth Drug Development December 2020 News Release

Published on Saturday January 02, 2021

New contracts were signed in December: • A contract for submission of the final report to the Ministry of Health of the Russian Federation. • Medical writing agreement with our long-term Sponsor.

Read more →

Smooth Drug Development November 2020 News Release

Published on Thursday December 03, 2020

New projects started in November: • Bioequivalence trial (INN: Azacitidine). • Medical writing project (INN: Amtolmetin guacil).

Read more →

Smooth Drug Development October 2020 News Release

Published on Tuesday November 03, 2020

We were working on the following new projects in October: • We signed a contract for data management and medical writing project of clinical study in Russia.

Read more →

Smooth Drug Development September 2020 News Release

Published on Tuesday October 06, 2020

We were working on the following new projects in September: • Observational trial is being initiated in dermatology • We signed a contract for a bioequivalence study (INN: Paracetamol) with long-term sponsor

Read more →

Smooth Drug Development August 2020 News Release

Published on Sunday September 06, 2020

We were working on the following new projects in August: • We are in the process of final negotiation of the contract for a BE study with a Czech company

Read more →

Smooth Drug Development July 2020 News Release

Published on Thursday August 06, 2020

We were working on the following new projects in July: • Our company signed a contract for a BE study (INN: Drotaverine) from a big Russian pharma • We finalized a contract for III phase study in patients with arthrosis • We won a tender performed by a leading Russian vaccine company for full services projects

Read more →